C ardiac senescence and the aging phenotype are characterized by a multitude of changes on the cellular and organ level that occur during the lifetime of an organism. In contrast to rapid expansion of nascent cardiomyocytes taking place in postnatal development, de novo generation of myocytes in response to aging is limited. [1] [2] [3] The onset of ventricular hypertrophy at the cellular and organ level is a hallmark of cardiac aging, which compensates for losses in cellular density and concomitant diminution of functional hemodynamic output. The consequence of pathological cardiac hypertrophy is eventual alterations in mitochondrial metabolism and energy homeostasis promoting glucose use over fatty acid oxidation (FAO), exacerbating disease. [4] [5] [6] Preservation of mitochondrial integrity and function antagonizes aging because myocardial senescence is associated, in part, with decreased mitochondrial content and altered metabolic function. [7] [8] [9] In This Issue, see p 325
Transcriptional coregulators, PPARγ coactivator-1 (PGC-1) α and β, serve as critical regulators of mitochondrial biogenesis and cellular ATP-producing pathways.
5,10-12 PGC-1α and PGC-1β coactivate downstream transcription factors involved in mitochondrial biogenesis, such as estrogen-related receptor alpha (ERRα), nuclear respiratory factor 1 (NRF1), and mitochondrial transcription factor A (TFAM). PGC-1α is enriched and highly inducible in the heart. However, ablation of PGC-1α leads to compensatory upregulation of PGC-1β. 4 ,5 PGC-1 coactivators regulate the mitochondrial FAO pathway, which serves as the primary supply for bioenergetic fuel in the healthy adult heart. Heart failure and hypertrophy prompt reprogramming of fuel use to rely predominantly on glucose metabolism similar to the fetal heart. 6 Downregulation of PGC-1 signaling and the cognate downstream target PPARα contributes to the fuel shift toward fetal metabolism in the hypertrophied heart presenting as metabolic dysfunction. 4, 13 Furthermore, transgenic mice with single knockdown of PGC-1α or PGC-1β demonstrate agedependent contractile dysfunction and impaired mitochondrial function, whereas mice lacking PGC-1α and PGC-1β die shortly after birth from heart failure. 4, 5, 14 Pim-1, a conserved serine/threonine protein kinase, exerts multiple protective effects on mitochondria and has recently been implicated in affecting metabolism through PGC-1α. [15] [16] [17] In addition, Pim-1 stabilizes and phosphorylates c-Myc, a known regulator of mitochondrial metabolism and biogenesis. 17, 18 Pim-1 also affects mitochondrial dynamics through phosphorylation and cytosolic sequestration of Drp1. 19 The Pim gene family consists of Pim-1, Pim-2, and Pim-3; 3 different genes transcribed from alternative start sites. All 3 Pim family members are constitutively active, exhibit similar substrate preferences, and differ primarily in tissue expression. 20, 21 Pim-1, the predominant isoform in the heart, can be genetically deleted in mice prompting compensatory upregulation of Pim-2 and Pim-3. 22, 23 Pim-1 is highly expressed in postnatal hearts but diminishes precipitously during postnatal development. 22 Recently, our group documented the remarkable ability of Pim-1 overexpression to rejuvenate aged human cardiac stem cells by decreasing senescent markers, promoting proliferation, and survival. 24 Taken together, these studies implicate Pim kinases in the maintenance and preservation of a youthful cellular phenotype. Because Pim-1 promotes mitochondrial integrity and antagonizes acquisition of an aging phenotype, the relationship among Pim kinase, mitochondrial biogenesis, cardiac senescence, and metabolism resulting from loss of Pim kinase activity is investigated in this report.
Methods

Mice and Echocardiography
Echocardiography was performed under mild isoflurane sedation (0.5%-1.5%) using a Vevo 770 high-resolution system with wild-type FVB and Pim triple knockout (PTKO) mice. 25 Cardiac function was analyzed in the parasternal long-axis view tracking the endocardium with the supplied analysis software to obtain left ventricle inner diameter during diastole, left ventricle anterior wall thickness during diastole, ejection fraction, and heart rate. We used the PTKO mouse model described by Mikkers et al. 25 Briefly, Pim-1 knockout mice were generated initially by homologus recombination using the targeting vector pGTP810 in FVB mice. Using Pim-1 knockout mice, PTKO mice were generated by deleting exons 1, 2, and 3 for Pim-2 with a PGK-Php cassette. Pim-3 exons 3, 4, 5, and 6 were deleted using a promoterless IRES-βGeo cassette.
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ATP Assay
Lysates for ATP assay and citrate synthase assay were obtained from nontransgenic wild-type and PTKO mice. Briefly, mouse hearts were extracted after cervical dislocation and immediately snap frozen in liquid nitrogen. Hearts were then homogenized in isolation buffer: 70 mmol/L sucrose, 190 mmol/L mannitol, 20 mmol/L HEPES solution, 0.2 mmol/L EDTA solution. Homegenized lysates were then used in an ATP assay (Invitrogen) according to the manufacturer protocol.
Cell Culture and Viral Transduction
Immortalized murine embryonic fibroblast from wild-type (iWT MEFs) and PTKO (iPTKO MEFs) mice were provided by Dr Andrew S Kraft (Medical University of South Carolina, Charleston, SC) and were cultured as previously described. 15 Briefly, immortalized MEFs were maintained in DMEM (Invitrogen 11965-092) containing 10% fetal bovine serum and 1% penicillin-streptomycin-glutamine. Adenovirus enhanced green fluorescent protein (EGFP) was created and expanded as previously described. 22, 26 The PGC-1α adenovirus is identical to that used in Lehman et al 27 2000 JCI. Adenovirus c-Myc was purchased from Vector Biolabs (Philadelphia, PA; Catalog# 1285) and expanded. For adenoviral transduction, iWT MEFs and iPTKO MEFs were infected in 2% fetal bovine serum DMEM for 2 hours followed by 2 wash steps of phosphate buffered saline and incubated in 10% DMEM and collected 24 hours later for analysis. A 50 multiplicity of infection was used for adenovirus EGFP, c-Myc, and 200 for PGC-1α.
Neonatal rat cardiomyocytes (NRCMs) were isolated and maintained as previously published. 19 Briefly, isolated NRCMs were maintained in 0.5% M199. siRNA transfections were performed as previously published using HiPerfect transfection reagent (Qiagen). 28, 29 siRNA for Pim-1, Pim-2, and Pim-3 were obtained from Sigma and used at a concentration of 50 nmol/L.
Mitochondrial Respiration Assay and Telomere Measurements
Mitochondrial isolation procedures were followed as previously published. 30 Telomeres were measured in nontransgenic wild-type and PTKO hearts using quantitative fluorescence in situ hybridization or multiplex quantitative polymerase chain reaction method as previously described. 23, 31 Further details are in Online Data Supplement.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 5.0 (Graphpad Software 
Results
Cardiac Hypertrophy Followed by Premature Cardiac Failure Is Evident in PTKO Mice
The expression of Pim kinases is differentially regulated in the myocardium over lifespan. Pim-1 expression is downregulated by 53% starting at 100 days after birth and remains 50% decreased at 324 days when compared with postnatal day 3 during physiological cardiac aging (P<0.01; Online Figure IA ). Pim-2 expression does not change with cardiac aging (Online Figure  IA) . Pim-3 expression is upregulated at postnatal day 14 by 2. Figure IB) . Pim-2 expression increases in the remote region at day 1 by 2.62-fold and also diminishes over time (Online Figure IC) . Pim-3 expression starts to decrease at 1 day after infarction in both the remote and the infarct regions and by 2 weeks it is decreased by 78% in infarct and remote regions (Online Figure ID) . Increased Pim expression early during myocardial infarction is consistent with a prosurvival role for Pim genes. Pathological hypertrophic remodeling during cardiac aging is well documented, 32, 33 as is the ability of Pim-1 to antagonize myocardial hypertrophy in response to pressure overload. 26 Expression of Pim-1, Pim-2, and Pim-3 kinases decrease by 62%, 81%, and 76% at 2 weeks, respectively, in response to transaortic constriction (Online Figure IE) . Consistent with hypertrophic remodeling, PGC-1α expression is diminished with trans aortic constriction by 59%, 72%, 88%, and 77% at 1 day, 4 day, 7 day, and 2 weeks, respectively (Online Figure IF) . Therefore, blunting of cardiac hypertrophy previously reported after Pim-1 overexpression 26, 34 was compared with the effect of Pim kinase deletion in PTKO mice. Cell size area was increased by 1.4-fold in PTKO mice at 1 month (P<0.001; Figure 1A and 1B). Increases were significant for Nppa (atrial natriuretic peptide; 19-fold; P<0.05), Nppb (brain natriuretic peptide; 2-fold; P<0.05), Acta1 (α-skeletal actin; 4-fold; P<0.01), and Myh7 (β-myosin heavy chain; 43-fold; P<0.05) after Pim Body weight and heart weight were decreased by 22% (P<0.001) and 27% in PTKO mice, respectively (P<0.001; Online Figure IIIA and IIIB). However, heart weight:body weight ratio was unchanged between PTKO and wild-type mice (Online Figure IIIC) . Smaller left ventricle interior diameter during diastole was revealed by longitudinal echocardiography from 1 to 6 months of age in PTKO mice (P<0.001; Figure 2A ). Furthermore, left ventricle anterior wall thickness during diastole demonstrated a strong trend toward increased wall thickness at 1 month and became significant at 3 months, showing an increase of 20% which persisted at 6 months (P<0.05; Figure 2B ). A 30% reduction in ejection fraction was evident at 6 months in PTKO mice, indicating premature cardiac failure (P<0.001; Figure 2C ). Heart rate was maintained at consistent levels to ensure comparability between individual measurements ( Figure 2D ). Consistent with cardiac hypertrophy and heart failure, markers of fibrosis collagen 1α1 and collagen 3α1 were upregulated 1.6-and 2.5-fold, respectively (P<0.01; Figure 2E and 2F). Furthermore, enlargement of the left ventricle in PTKO mice was evident by Massons trichrome staining ( Figure 2G and 2H). Collectively, these findings demonstrate hypertrophic remodeling in PTKO mice and progression toward failure at 6 months.
Markers of Senescence Are Elevated With Loss of Pim Kinases
Senescent markers characterization was performed to determine the aging phenotype in PTKO mice. p16 expression was evident throughout the myocardium of PTKO mice at 3 months, indicating irreversible cellular senescence ( Figure 3A) . Increased p16 expression was confirmed by immunoblot in PTKO mice relative to nontransgenic controls ( Figure 3B ). p16 upregulation was validated by a concurrent reduction in p16 transcriptional repressors Id1 and Id2 by 60% and 64% in PTKO cardiac lysates, respectively (P<0.05, P<0.01; Online Figure IVA and IVB). Moreover, increased Ets-1 level (p16 transcriptional activator, 2.4-fold) also supports p16 induction (P<0.01; Online Figure IVC ). p53 showed a 2.5-fold increase in PTKO mice at 3 months (P<0.01; Figure 3C ) consistent with reduction of mouse double minute 2 homolog (MDM2) (p53 ubiquitin ligase MDM2; 57% lower; P<0.01; Figure 3D ). Telomere mean fluorescence intensity was diminished by 41.5% in PTKO mice as measured by quantitative fluorescence in situ hybridization (P<0.001; Figure 3E and 3F). In addition, telomere length was decreased by 40% in PTKO mice by quantitative polymerase chain reaction analysis (P<0.01; Figure 3G ). The collective phenotypic profile observed is consistent with expectations for premature cardiac senescence and predisposition toward heart failure in PTKO mice.
Knockdown of Pim-1, Pim-2, and Pim-3 in NRCMs stimulated an increase in p53 by 1.6-fold (P<0.05), whereas p16 expression was unchanged (Online Figure VA-VD) . Furthermore, NRCMs treated with physiological (insulin) or pathological (phenylephrine) growth stimulus promoted an increase in p53 with loss of Pim-1, Pim-2, and Pim-3 by 2-fold (P<0.001) and 1.9-fold (P<0.01), respectively (Online Figure VA and VB) . p16 gene expression was unchanged when compared with respective scrambled controls during stress (Online Figure VC and VD) . Upregulation of Nppa by 1.4-fold (P<0.05), Nppb by 1.4-fold (P<0.05), and Myh7 by 2.5-fold was also noticed in NRCMs knocked down for Pim-1, Pim-2, and Pim-3, whereas α-skeletal actin displayed a strong increasing trend (Online Figure VE) . Validation of siRNA efficiency resulted in 80%, 80%, and 67% decrease in gene expression of Pim-1, Pim-2, and Pim-3, respectively (P<0.001; Online Figure VF-VH). These data further endorse the premature cardiac aging phenotype of PTKO mice.
Mitochondrial Morphological and Functional Aberrations Occur With Loss of Pim
Pim-1 protects mitochondrial integrity and preserves mitochondrial morphology. 16, 19 Mitochondrial vacuoles and disrupted cristae structures were evident by electron microscopy in hearts of PTKO mice at 1 month after birth ( Figure 4A ). In addition, mitochondrial area and mitochondrial area per section were decreased by 11% and 10% in PTKO mouse hearts, respectively (P<0.05; Figure 4A ). Validating these results, voltage-dependent anion channel expression was reduced by 16% in cardiac lysates of PTKO mice, indicating a reduction in mitochondrial mass (P<0.05; Figure 4B ).
Loss of mitochondrial function is consistent with a reduction in energy reserve as revealed by analysis of ATP levels ( Figure 4C ). Corroborating these results, an increase in the ratio of phosphorylated AMP-activated protein kinase (AMPK) to total AMPK by 4-fold was noted in PTKO hearts by immunoblot (P<0.01; Figure 4D ). Collectively, these results reveal alterations in mitochondrial morphology and functional capacity leading to energy deficiency resulting from loss of Pim kinases.
Metabolic Regulators Are Decreased With Deletion of Pim Kinases
Pim kinase deletion impairs expression of PGC-1α, 15 with loss of PGC-1 coactivators promoting alteration of mitochondrial morphology. 4 Therefore, the effect of Pim kinase deletion on expression of PGC-1 coactivators and downstream metabolic regulators was assessed. PGC-1α and PGC-1β expression were decreased by 42% and 82%, respectively, in PTKO cardiac lysates at 1 month (P<0.05; Figure 5A ). Furthermore, downstream transcriptional targets of PGC-1 coactivators, including Errα, Nrf1, and Tfam (mitochondrial transcription factor A), were also decreased, respectively, by 44% (P<0.05), 83% (P<0.01), and 81% (P<0.01) in PTKO mice ( Figure 5A ). Peroxisome proliferative activated receptor gamma coactivatorrelated protein (PPRC1) was also diminished by 73% with Pim loss, evidently revealing lack of compensatory upregulation for related proteins (P<0.05; Online Figure VIA) . Furthermore, decrease in PGC-1α (30%) and PGC-1β (20%) was confirmed at the protein level by immunoblot, corroborating gene expression analysis of PGC-1 coactivators (P<0.05; Figure 5B and 5C). July 18, 2014
Mitochondrial biogenesis is also dependent on c-Myc expression that is a downstream target of Pim kinase. 17, 18 cMyc protein levels were diminished by 36% in PTKO mice (P<0.01; Figure 5D ). The effect of decreased regulators of mitochondrial biogenesis is apparent by measurement of mitochondrial DNA content as a correlate for mitochondrial number that was reduced by 50% in PTKO mice, consistent with decreased expression of PPARγ coactivators with Pim deletion (P<0.05; Figure 5E and 5F).
Decreased expression of PGC-1 coactivators alters the expression profile of cardiac metabolic genes, 5, 6, 9 so representative genes involved in FAO, glycolysis, and oxidative phosphorylation were assessed. FAO-related enzymes located in the inner mitochondrial membrane were decreased, including Acate3 (acyl coenzyme A thioesterase 3; 14.9-fold; P<0.001), Acadv1 (aceyl coenzyme A long chain; 6.9-fold; P<0.001), and Acadm (FAO-acetyl CoenzymeA dehydrogenase; 1.7-fold; P<0.01; Figure 6A ). In contrast, transporters of fatty acids, such as Cpt1b Average heart rate during echocardiography measurements. E and F, Gene expression analysis of collagen 1α1 and collagen 3α1 in cardiac tissue. G and H, Low-magnification image of nontransgenic (NTG) and PTKO hearts with trichrome staining. n=8 NTG and n=9 PTKO. *, **, and *** are significant compared with NTG mice at each individual time point. *P<0.05, **P<0.01, and ***P<0.001.
(carnatine palmitoyl transferase) and Cpt2 (carnatine palmitoyl transferase 2), were increased by 3.3-fold (P<0.001) and 2.3-fold (P<0.01), respectively, consistent with previous literature demonstrating upregulation of fatty acid transporters with prolonged AMPK activation ( Figure 6A) . 35 The rate-limiting step of glycolysis involves Hk2 (hexokinase 2) that was reduced by 15.3-fold (P<0.001; Figure 6B ) in PTKO hearts. Conversely, downstream targets involved in the glycolytic pathway: Pfk , and MDM2, respectively, in total cardiac lysates n=3 NTG and n=3 PTKO mice at 3 months. E and F, Representative quantitative fluorescence in situ hybridization images and quantification normalized to mean fluorescence intensity (MFI) in NTG (n=3) and PTKO (n=3) mice at 3 months. G, Quantitative polymerase chain reaction measurements of telomere lengths in NTG (n=6) and PTKO (n=6) at 1 month. *, **, and *** are significant when compared with NTG mice. *P<0.05, **P<0.01, and ***P<0.001.
(phosphofructokinase), Pdha1 (pyruvate dehydrogenase E1 alpha 1), and Pfkfb2 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2) were highly upregulated by 3-fold (P<0.001), 3.6-fold (P<0.001), and 3.3-fold (P<0.001; Figure 6B ). Furthermore, pyruvate respiration was increased, whereas succinate respiration was unaltered (P<0.05; Online Figure VIB and VIC), indicating a shift away from FAO and toward glucose metabolism similar to PGC-1α/β double knockouts. 4 Genes involved in lipid sterol biosynthesis were also dramatically reduced in cardiac tissue of PTKO mice, indicating disruption in the PPAR signaling circuit (P<0.05; Online Figure VID) . mRNA analysis for genes involved in oxidative phosphorylation, NDUFA (NADH dehydrogenase 1 alpha subcomplex subunit 9), NDUFV (NADH dehydrogenase ubiquinone flavoprotein 1), and Idh2 (isocitrate dehydrogenase 2), revealed upregulation of 3.8-fold (P<0.001), 2.2-fold (P<0.001), and 2.9-fold (P<0.001), respectively ( Figure 6C ). However, Cytc (cytochrome C), a target of PGC-1α, was decreased by 8-fold (P<0.001; Figure 6C ). To assess global changes, a microarray analysis of PPAR signaling genes involved in FAO, transport, and lipid sterol biosynthesis was performed, confirming altered expression of genes involved in the PPAR signaling pathway (Online Figure VII) . Sixty-two PPAR-related signaling genes were detected in cardiac tissue, 32 showed a downregulation, 21 genes remained unchanged, and 8 genes were induced. Three of the 4 genes included in the targeted screen (Acadm, PGC-1α, Cpt1b, and Cpt2) demonstrated similar results to our targeted approach. Acadm and PGC-1α were downregulated, whereas Cpt1b was upregulated. Cpt2 was upregulated in our screen and was unchanged in the microarray, this discrepancy might be because of differences in primer pairs because Cpt2 is predicted to have 5 alternatively spliced transcripts (NCBI: AceView). Taken together, these results demonstrate disruption of metabolic processes with Pim ablation mimicking the phenotype of PGC-1α/β double knockouts. 
c-Myc Rescues Expression of Metabolic Regulators
The metabolic phenotype of PTKO mice correlates with loss of c-Myc expression secondary to Pim kinase ablation, so the participation of c-Myc was assessed by a rescue experiment involving overexpression of PGC-1α, c-Myc, and Pim-1 using iWT MEFs and PTKO (iPTKO MEFs) mice. Metabolic deficiencies in the iPTKO MEFs were confirmed to be comparable with those of PTKO cardiac lysates. Expression of c-Myc and PGC-1α was diminished by 82% and 55%, respectively, in iPTKO MEFs (P<0.05; Online Figure VIIIA ) similar to PTKO mouse hearts. Phosphorylated AMPK:total AMPK ratio was increased in iPTKO MEFs by 2.3-fold consistent with decreased cellular energy stores (P<0.05; Online Figure VIIIB) . Similarly, alterations of metabolic regulators and reduction in FAO enzymes were comparable between iPTKO MEFs and PTKO heart lysates (Online Figure VIIIC) . Because the iPTKO Figure 5 . PPAR coactivators and downstream targets are decreased with Pim deletion. A, mRNA levels of PGC-1α, PGC-1β, estrogen-related receptor alpha (Errα), nuclear respiratory factor 1 (NRF1), and mitochondrial transcription factor A (TFAM) in 1 month nontransgenic (NTG; n=6) and PTKO (n=6) hearts. B-D, Protein analysis of PGC-1α, PGC-1β, and c-Myc, respectively, in cardiac samples; NTG (n=6) and PTKO (n=7) hearts. E and F, Mitochondrial DNA analysis of Cox1 and Cytochrome B normalized to β-globin; NTG (n=4) and PTKO (n=4). * and ** are significant when compared with NTG mice. *P<0.05 and **P<0.01. CSQ indicates calsequestrin.
MEFs possess analogous metabolic derangements to PTKO heart samples, molecular restorations were attempted by overexpression of c-Myc, PGC-1α, or Pim-1. Overexpression of EGPF, Pim-1-EGFP, PGC-1α-EGFP, and c-Myc-EGFP adenovirus was confirmed in iPTKO MEFs (Online Figure VIIID) Figure 7B ). PGC-1α overexpression in iPTKO MEFs restored gene expression of the PGC-1α downstream targets: Errα and Acadv1 by 2.3-and 1.8-fold, respectively (P<0.001; Figure 7C ). Consequential to increased metabolic regulator expression, the ratio of phosphorylated AMPK:total AMPK decreased by 34% (P<0.01) with c-Myc, 35% with Pim-1, and 41% (P<0.01) with PGC-1α overexpression, indicating improvement in cellular energy stores after interventions to overexpress c-Myc, Pim-1, or PGC-1α ( Figure 7D-7F) . In summary, the phenotype resulting from loss of Pim kinases can be rescued with overexpression of c-Myc, Pim-1, or PGC-1α.
Discussion
Cardiac aging is characterized by pathological hypertrophic remodeling that is a primary indicator of and confirmed risk factor for heart failure. 33 Pathological hypertrophy and progression toward heart failure were evident at 6 months in PTKO mice (Figures 1 and 2 ) consistent with previous published studies demonstrating antagonism of myocardial hypertrophy by Pim-1. 26 Increased AKT phosphorylation and RCAN1.4 expression, a readout for activated NFAT, was evident with loss of Pim, which serve as molecular underpinnings for hypertrophic signaling (Online Figure II) and remodeling. In addition, fetal gene reprogramming typical for hypertrophic stimulation is blunted by Pim-1 overexpression. 26 Promotion of hypertrophic effects at the molecular, cellular, and organ levels in PTKO hearts is relatively early in life (Figure 1) , and enhanced senescence marker expression (Figure 3) is consistent with Pim kinase deletion manifesting with features of an accelerated aging phenotype.
Pathological hypertrophic remodeling causes an energetic fuel shift from FAO to glucose metabolism. 6 Cellular metabolic changes are potent regulators of the aging phenotype and PTKO mice demonstrate an upregulation of glycolytic enzymes and diminished FAO enzymes, exhibiting metabolic alterations ( Figure 6 ). Mitochondrial metabolism and energetics converge on the PPAR signaling circuit and the influence of Pim kinases on PGC-1α is established. 5, 15 Now for the first time to our knowledge, the connection between downregulation of PGC-1 α and β and downstream targets affected by Pim kinase deletion has been revealed in the heart by our results ( Figure 5 ). Furthermore, PGC-1α is important and necessary to maintain a pool of healthy mitochondria because PGC-1α regulates mitochondrial biogenesis. 27 Disruption in mitochondrial biogenesis occurs during aging causing accumulation of unhealthy mitochondria and potential increases in toxic metabolic byproducts that potentially accelerate cellular aging. 36 Diminished PPAR signaling occurs with aging in human and in murine animal models, supporting our contention that disrupted metabolism and diminished mitochondrial biogenesis through loss of PGC-1α in PTKO mice contributes to premature aging. 37, 38 Downstream of Pim kinases is c-Myc, a potent regulator of mitochondrial biogenesis and PGC-1β. 18, 39, 40 Diminished expression of c-Myc was evident in PTKO hearts and iPTKO MEFs ( Figure 5D ; Online Figure VIIIA) . Acute overexpression of c-Myc in iPTKO MEFs promoted upregulation of PGC-1α and PGC-1β in addition to downstream regulators of mitochondrial biogenesis. c-Myc activation during pathological cardiac injury is shown to promote glucose metabolism by down regulating PPARγ coactivators. 18 In comparison, the observed loss of c-Myc still prompted enhanced glycolytic enzyme expression in PTKO mice, suggesting alternative mechanism(s) for promotion of glucose metabolism in PTKO mice. The loss of Pim kinase consequently promotes diminished expression of c-Myc along with PPARγ coactivators presenting as cellular metabolic alterations consistent with acquisition of an aging phenotype.
Mitochondria play a central role in energy metabolism, with mitochondrial morphology intimately tied to mitochondrial function. 36 Pim kinases protect mitochondrial integrity by upregulating antiapoptotic B-cell lymphoma 2 (Bcl-2) family members (Bcl-2 and Bcl-XL [B-cell lymphoma-extra large]) and phosphorylating BAD on serine 112. 16, 34 Furthermore, Pim-1 regulates mitochondrial morphological dynamics by regulating Drp1 localization and phosphorylation. 19 Imbalance in mitochondrial fission sensitizes mitochondria to cell death in addition to promoting formation of smaller mitochondria as seen in PTKO hearts ( Figure 4A ). Pim deletion also prompted altered mitochondrial morphology and disarray of myofibrils ( Figure 4A ). Mitochondrial morphology alterations can increase apoptotic sensitivity to cell death and propensity to permeabilize in response to stress. Disruption of mitochondrial dynamics occurring with Pim loss promotes instability in mitochondrial DNA, 19, 41 and reduction in mitochondrial DNA content precedes pathological hypertrophy. 42 Consistent with these assertions, PTKO mice display diminished levels of mitochondrial DNA content before heart failure ( Figure 5E and 5F) that can serve as an additional predisposing factor for premature aging at the mitochondrial level with loss of Pim.
Telomere attrition disrupts mitochondrial function through a molecular mechanism involving p53-mediated cellular senescence leading to a p53-dependent repression of PGC-1α. 43 Telomere length decrease in PTKO mice ( Figure 3E-3G ) is a plausible inductive mechanism for upregulation of p53 activity and subsequent blunting of PGC-1α. Conversely, increased telomere length resulting from Pim-1 kinase overexpression is associated with decreased expression of senescent markers including p53 and increased cell cycling in human cardiac progenitor cells. 24 Comparable beneficial effects of telomere length maintenance are also observed after Pim-1 kinase overexpresssion in murine cardiac progenitor cells. 23 Furthermore, PTKO mice at 4 weeks exhibit an accelerated aging phenotype evident by telomere attrition of 40% by quantitative polymerase chain reaction and fluorescence in situ hybridization ( Figure 3E-3G ). This dramatic decrease would be comparable with the relative age of 30 months in a normal mouse. 3 Increased cellular turnover during physiological aging leads to a reduction in telomere length with each cell division. [44] [45] [46] Although Pim-1 deletion blunts cellular proliferation that may help slow telomeric shortening, any modest beneficial effect is apparently overwhelmed by the depression of TERT (telomerase reverse transcriptase) activity that compromises preservation of telomere length, 23 leading to telomeric shortening in PTKO mice consistent with accelerated physiological aging. Therefore, the effect of Pim kinase on telomere biology highlights an important potential mechanism affecting mitochondrial function and causing cellular senescence that is the subject of ongoing investigation. Pim kinases promote proliferation by regulating cell cycle proteins, such as p21, p27, and cdc25A, through phosphorylation. [47] [48] [49] Furthermore, Pim phosphorylation and stabilization of c-Myc enhance cell cycle entry, 17 leading to the plausible idea that Pim kinases antagonize the aging phenotype and favor ongoing mitotic activity by blunting the effect of cell cycle inhibitors. Indeed, downregulation of cell cycle inhibitors p16 and p53 leading to increased proliferation occurs in aged and senescent human cardiac progenitor cells overexpressing Pim-1 kinase. 24 Conversely, in PTKO mice, the increased expression of p16 and p53 supports a role for the Pim kinase family in preserving phenotypic characteristics of cellular youthfulness (Figure 3 ; Online Figure V) .
The cardioprotective activity of Pim-1 through the preservation of mitochondrial structure and morphology is well established primarily based on the overexpression of Pim-1. 16, 19 However, the converse of this experimental approach implies that the loss of Pim kinase would promote deterioration of mitochondrial structure and function. Such diminution of Pim kinase occurs naturally with organismal aging, but ours is the first assessment of germline deletion for all 3 Pim kinase family members on myocardial biology. Degenerative changes in mitochondria, such as altered structural integrity, shifts in metabolic fuel selectivity, and decreased ATP production, are hallmarks of cellular aging and senescence. 50 Clearly, select essential features of the aging and senescent phenotype are recapitulated with accelerated timing in the PTKO line. Now a link can be placed to connect Pim kinases to aging and metabolic changes through the PPAR signaling circuit. Important to note as a limitation of this study is the PTKO mouse models are global knockouts and not cardiac specific. Therefore, in vivo findings although consistent with expectations remain correlative in nature, so these findings were buttressed by mechanistic molecular signaling in vitro studies with iPTKO MEFs. At present, the circumstantial evidence points toward alterations in mitochondrial biogenesis and metabolism coincident with premature cardiac aging of PTKO hearts. Looking forward to an interventional strategy, prevention of metabolic derangements is important to antagonize the cardiac aging phenotype. So too, delineating underlying causes of aging are important to develop therapeutic interventions to treat aging myopathy in the elderly population. The PTKO mouse model could serve in this capacity as an excellent model system to study cardiac aging and senescence. Collectively, this study gives credence to the possibility of using Pim-1 as a therapeutic agent for treatment of and intervention in the pathogenesis of cardiac aging.
Myocardial aging leads to deterioration of cardiac function promoting onset of heart failure, in part by, altered metabolism. Preventing deterioration of mitochondrial function is known to blunt cardiac aging and avert heart failure. Pim kinases promote cell proliferation, survival, and preserve mitochondrial integrity in the cardiac context. Therefore, Pim kinase-mediated protection of mitochondrial function was hypothesized to antagonize phenotypic consequences of aging associated with metabolic derangement. Cardiac metabolism depends on mitochondrial function that is regulated by PPARγ coactivator-1 α signaling to stimulate fatty acid oxidation. Heart failure prompts decreased fatty acid oxidation and a concomitant increase in glycolytic metabolism that devolves into declining energy reserves. Loss of Pim kinases caused premature heart failure and was coincident with decreased PPARγ coactivator-1 α signaling, altered cardiac metabolism, and decreased ATP levels. Conversely, overexpression of Pim-1, the major cardiac isoform, in Pim triple knockout immortalized murine embryonic fibroblast rescued metabolic gene expression and increased energy reserves. Therefore, taken together with ability of Pim-1 overexpression to blunt the expression of senescence markers in human cardiac progenitor cells and maintain mitochondrial integrity, our findings reveal novel beneficial properties imparted by Pim-1, lending further support for activation of Pim-1 as a therapeutic modality to inhibit cardiac aging and failure by preserving mitochondrial function and healthy metabolic activity.
Novelty and Significance
